Aderis Pharmaceuticals

United States
Forest Hill, Texas, United States
(804)358-9468 ★

Company profile

Aderis Pharmaceuticals company profile

Aderis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovery, development and commercialization of products for the diagnosis and treatment of cardio-renal diseases. Discovery Therapeutics' product pipeline includes adenosine agonists and antagonists for the diagnosis and treatment of cardiovascular disease and leukotriene synthesis inhibitors for the treatment of chronic renal disease. In addition the company has license agreements with strategic partners involving novel late stage products for the treatment of Parkinson's disease and diagnosis of coronary artery disease.

Business identity

Contact email
[email protected]
Phone number
(804)358-9468
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
1994-01-01

Headquarters

Headquarters
Forest Hill, Texas, United States
Postal code
23230
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Total equity funding
$45M
Last funding
Series D / $45M / 2001-10-09
Last equity funding
Series D / $45M
Investors
10
Lead investors
1
Articles
1
Exited on
2005-07-15

Founders and investors

Lead investors

Paladin Capital Group

Investors

MDS CapitalNeomed ManagementPaladin Capital GroupSchroder VenturesTemasek Holdings

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.